Stereotaxis, Inc. is projected to rise to $1.66 by 2027, a +32% move from its current price of $1.26. STXS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $1.22 | $1.26 | $1.30 | 0.00% |
| Aug 5 | $1.21 | $1.26 | $1.32 | 0.00% |
| Aug 6 | $1.19 | $1.26 | $1.33 | -0.01% |
| Aug 7 | $1.18 | $1.26 | $1.34 | -0.01% |
| Aug 8 | $1.18 | $1.26 | $1.35 | -0.01% |
| Aug 9 | $1.17 | $1.26 | $1.36 | -0.01% |
| Aug 10 | $1.16 | $1.26 | $1.37 | -0.01% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.16 | $1.26 | $1.37 | -0.01% |
| Week 2 | $1.12 | $1.26 | $1.42 | -0.03% |
| Week 3 | $1.09 | $1.26 | $1.45 | -0.04% |
| Week 4 | $1.07 | $1.26 | $1.49 | -0.05% |
| Week 5 | $1.05 | $1.26 | $1.51 | -0.07% |
| Week 6 | $1.03 | $1.26 | $1.54 | -0.08% |
| Week 7 | $1.01 | $1.26 | $1.57 | -0.09% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems.
It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices. Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices.
Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
Stereotaxis, Inc. (STXS) trades at $1.29 per share and has a market cap of $128.52M, ranking 3864. The stock operates within the Healthcare category.
A major floor 33.3% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 50.0% above — a clean break opens room to run.
A major ceiling 66.7% above — clearing it would confirm fresh momentum.
Key STXS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of STXS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.30 | Sell | $1.31 | Sell |
| MA 10 | $1.37 | Sell | $1.37 | Sell |
| MA 20 | $1.53 | Sell | $1.48 | Sell |
| MA 50 | $1.72 | Sell | $1.65 | Sell |
| MA 100 | $1.80 | Sell | $1.81 | Sell |
| MA 200 | $2.13 | Sell | $2.00 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 27.56 | Buy |
| Stoch RSI (14) | 15.01 | Buy |
| CCI (20) | -108.86 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -22.22 | Sell |
| Bollinger %B (20,2) | 0.15 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.91 | Sell |
| Awesome (5,34) | -0.33 | Sell |
| Ultimate (7,14,28) | 19.70 | Buy |
| Momentum (10) | -0.29 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 1.28 | Sell |
| ADX (14) | 28.75 | Sell |
| ATR (14) | 0.05 | Info |
The current technical picture shows neutral sentiment. RSI14 is 30, with the 50-day moving average at $1.78 and the 200-day moving average at $2.19. A nearby support level sits at $1.41 while resistance is at $1.89. Over the last 30 days, the price has traded in a range from $1.07 to $1.56, and the stock’s annualized volatility is 50%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.26 | $1.26 | $1.76 | 0% | Neutral | |
| $1.31 | $1.66 | $2.24 | +32% | Bullish | |
| $1.35 | $1.77 | $2.49 | +40% | Bullish | |
| $1.27 | $1.72 | $2.50 | +36% | Bullish | |
| $1.29 | $1.78 | $2.66 | +42% | Bullish | |
| $1.28 | $1.80 | $2.76 | +43% | Bullish | |
| $1.33 | $1.92 | $3.00 | +53% | Bullish | |
| $1.56 | $2.29 | $3.65 | +82% | Bullish | |
| $1.69 | $2.53 | $4.10 | +101% | Bullish | |
| $1.81 | $2.75 | $4.53 | +118% | Bullish | |
| $2.18 | $3.60 | $6.34 | +185% | Bullish | |
| $3.02 | $5.73 | $11.14 | +355% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.26 | $1.26 | $1.56 | +0.00% |
| September 2026 | $1.07 | $1.27 | $1.56 | +1.15% |
| October 2026 | $1.05 | $1.26 | $1.56 | -1.31% |
| November 2026 | $1.10 | $1.33 | $1.66 | +5.42% |
| December 2026 | $1.15 | $1.40 | $1.76 | +5.29% |
Click any year to see its month-by-month STXS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, STXS is projected to trade between $1.26 and $1.76, averaging $1.26 — a potential gain of 0% from today's $1.26. A consolidation phase looks the most probable path here.
Stereotaxis, Inc.'s 2027 outlook centres on $1.66, within a $1.31 to $2.24 range. That is up +32% on the projected 2026 average. That marks a +32% change versus current levels. Momentum favours further upside here.
By 2028, STXS could reach as high as $2.49, with a base case around $1.77 and support toward $1.35 — roughly +40% from $1.26. Buyers look set to stay in control over this stretch.
Expect STXS to range from $1.27 to $2.50 through 2029. The $1.72 average target implies a +36% move from current prices. That is -3% versus the projected 2028 average. Momentum favours further upside here.
The STXS price prediction for 2030 points to an average of $1.78 (low $1.29, high $2.66) — a potential gain of +42% on today's $1.26. Buyers look set to stay in control over this stretch.
In 2031, STXS is projected to trade between $1.28 and $2.76, averaging $1.80 — a potential gain of +43% from today's $1.26. That is up +1% on the projected 2030 average. Momentum favours further upside here.
Stereotaxis, Inc.'s 2032 outlook centres on $1.92, within a $1.33 to $3.00 range. That is up +7% on the projected 2031 average. That marks a +53% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, STXS could reach as high as $3.65, with a base case around $2.29 and support toward $1.56 — roughly +82% from $1.26. Momentum favours further upside here.
Expect STXS to range from $1.69 to $4.10 through 2034. The $2.53 average target implies a +101% move from current prices. That is up +10% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The STXS price prediction for 2035 points to an average of $2.75 (low $1.81, high $4.53) — a potential gain of +118% on today's $1.26. Momentum favours further upside here.
In 2040, STXS is projected to trade between $2.18 and $6.34, averaging $3.60 — a potential gain of +185% from today's $1.26. That is up +31% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Stereotaxis, Inc.'s 2050 outlook centres on $5.73, within a $3.02 to $11.14 range. That is up +59% on the projected 2040 average. That marks a +355% change versus current levels. Momentum favours further upside here.
Investing $1,000 in STXS today (≈ 793.650794 STXS) could be worth
$4,546.76
+$3,546.76 (+355%) by 2050 · US Dollar
Based on the average projected STXS price of $5.73 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in STXSwould be worth at today's price.
$1,000 invested in STXS on Jul 31, 2025 (≈ 440.528638 STXS) would be worth
$555.07
-$444.93 (-44.5%) today · 0.56× · US Dollar
Based on a STXS entry price of $2.27 vs. today's $1.26.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.29 | $976.74 | -2.3% |
| 1 month ago | $1.77 | $711.86 | -28.8% |
| 3 months ago | $1.93 | $652.85 | -34.7% |
| 6 months ago | $2.21 | $570.14 | -43.0% |
| 1 year ago | $2.27 | $555.07 | -44.5% |
| All time (5.0y) ago | $8.93 | $141.1 | -85.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our STXS forecast.
Our base-case forecast reaches $2.50 around 2034.
Implied market cap at $2.50: $249.07M
The multi-year forecast turns bullish after 2026, with rising averages and sizable upside projections. In 2030, the average price is forecast at $1.87 with a max of $2.73 and a min of $1.38, yielding a 44.7% return on investment and a bullish sentiment. The forecast extends through 2040, where the average is $3.97 and the max is $6.78, delivering a 207.6% ROI and continuing bullish sentiment.
By 2050, the average reaches $6.38 with a max of $11.96 and a 394.5% ROI, still labeled bullish. The path includes earlier years with gradual increases (e.g., 2027 avg $1.68; 2028 avg $1.82; 2029 avg $1.77) and a sustained bullish trajectory toward the long view. These figures represent estimates and are not guarantees; actual results may differ.
Drivers and risks are inherent in any forward-looking projection and should be considered alongside other factors when evaluating the asset.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $1.87 with a minimum of $1.38 and a maximum of $2.73, and a ROI of 44.7% with a bullish sentiment.
Forecasts from 2027 onward are bullish, with rising average prices through 2050 and increasing ROI, but these are estimates and not guarantees.
Yes. The 2050 forecast lists a max of $11.96, with an average of $6.38 and a ROI of 394.5%, indicating reaching $10 is within the max scenario by 2050.
The 30-day range is $1.07 to $1.56.
Stereotaxis, Inc. Community Discussion
0Share your Stereotaxis, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.